Matinas BioPharma Holdings, Inc. MTNB
0.80 USD -0.01 (-1.26%)
Regular-session close
0.77 -0.03 -3.81%
After hours · Nov 20, 4:00 PM ET
0.7501 Day range 0.80
0.585 52-week range 13.08
- YTD
- +36.50%
- 1 year
- -4.77%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -6.92M | -24.59M | -23.77M | -24.59M | -24.73M | |
| -10.35M | -24.25M | -22.94M | -21.00M | -23.28M | |
| -30.00 | -75.00 | -79.00 | -75.00 | -82.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 4.00M | 7.28M | 4.79M | 6.83M | 21.03M | |
| 7.21M | 12.64M | 25.10M | 44.82M | 61.33M | |
| 2.38M | 5.05M | 5.86M | 8.18M | 8.83M | |
| 1.35M | 2.89M | 3.56M | 4.12M | 4.70M | |
| 4.83M | 7.59M | 19.25M | 36.64M | 52.49M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -7.01M | -15.88M | -15.28M | -19.16M | -15.22M | |
| 335.00K | 9.21M | 13.24M | 4.88M | 16.77M | |
| 3.39M | 9.17M | -7.00K | 79.00K | 6.96M | |
| 335.00K | 0 | -218.00K | -892.00K | -260.00K | |
| -3.29M | 2.50M | -2.04M | -14.20M | 8.51M |
